Musgrove Park Hospital is a large NHS hospital located in Taunton, Somerset, England, run by Somerset NHS Foundation Trust. Originally a US Army General Hospital during the Second World War, it became an NHS hospital in 1951.

There are 640 beds in Musgrove Park Hospital.

During the past decade, Musgrove Park Hospital conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 15 clinical trials were completed, i.e. on average, 46.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 10 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Musgrove Park Hospital" #1 sponsor was "University College, London" with 5 trials, followed by "Clovis Oncology, Inc." with 3 trials sponsored, "Institute of Cancer Research, United Kingdom" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Lisette Nixon" with 2 trials sponsored. Other sponsors include 44 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Musgrove Park Hospital" #1 collaborator was "Cancer Research UK" with 7 trials as a collaborator, "Foundation Medicine" with 3 trials as a collaborator, "Boehringer Ingelheim" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "Cancer Trials Ireland" with 2 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "Musgrove Park Hospital" are "Atrial Fibrillation" (3 trials), "Breast Cancer" (3 trials), "Crohn Disease" (3 trials), "Prostate Cancer" (3 trials) and "Cancer" (2 trials). Many other conditions were trialed in "Musgrove Park Hospital" in a lesser frequency.

Most popular intervention types in "Musgrove Park Hospital" are "Drug" (41 trials), "Procedure" (11 trials), "Other" (9 trials), "Biological" (7 trials) and "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Paclitaxel" (4 trials), "Carboplatin" (3 trials), "Cisplatin" (3 trials) and "Rucaparib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Musgrove Park Hospital" are 50 trials for "All" genders, 8 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Musgrove Park Hospital". undefined are not yet recruiting, 8 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Musgrove Park Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Musgrove Park Hospital, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 14 trials that are defined as “Not Applicable".